InCarda Therapeutics incardatherapeutics.com


Public list: BIO 2016 (619) Pharma Startups (6570)

InCarda Therapeutics is a product-focused cardiovascular company with significant capabilities and experience in drug development. The lead product under development is an inhaled therapy intended to treat Paroxysmal atrial fibrillation (PAF). InCarda is also working on additional research concepts that leverage the same platform technology to target the heart for acute cardiac conditions.

InCarda Therapeutics is a product-focused cardiovascular company with significant capabilities and experience in drug development. The lead product under development is an inhaled therapy intended to treat Paroxysmal atrial fibrillation (PAF). InCard...Show all

Company (Alive / Active)

All investors data 6 Investors

Phone: 408-219-2576

Fax:

39899 Balentine Drive
Suite 185
 Newark, 94560
 California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
InCarda Therapeutics $49.5M Nov 8, 2018

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related InCarda Therapeutics Jobs

jobs by Indeed job search

Investors

Investor Investor Type Location Participating Rounds
See all 6 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration Mar 18, 2010 Mar 10, 2015 Patent
Combining electronic monitoring with inhaled pharmacological therapy to manage cardiac arrhythmias including atrial fibrillation Feb 01, 2017 Application
Unit aerosol doses for anticoagulation Jan 20, 2016 Application
Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration Feb 26, 2015 Application